Submit Deal

Submit Deal

Cover Image David A. Ricks

David A. Ricks

Chairman and CEO at ELI LILLY AND COMPANY

Manager

Deal Bio

Total Deals16

Valued Deals15

Total Value£ 15.55 B

Avg. Deal Size£ 1.04 B

Market Context

Privacy Policy Terms of Service Contact Us Cookie Preferences

All rights reserved. Copyright © 2025 Datasite

MergerLinks - David A. Ricks

Sort

07 Jan 2019|United States|Biotechnology

Target: LOXO ONCOLOGY INC

Bidder: ELI LILLY AND COMPANY

6 Service Providers

3 Target | 3 Bidder

55 Dealmakers

33 Target | 22 Bidder

£ 6.28 B

Value

10 Jan 2020|United States|Pharmaceuticals

Target: DERMIRA INC

Bidder: ELI LILLY AND COMPANY

8 Service Providers

5 Target | 3 Bidder

41 Dealmakers

26 Target | 16 Bidder

£ 838 M

Value

02 Mar 2020|United Kingdom|Biotechnology

Target: IMMUNOCORE

Bidder: JDRF

11 Service Providers

2 Target | 9 Bidder

30 Dealmakers

9 Target | 21 Bidder

£ 101 M

Value

15 Oct 2020|United States|Biotechnology

Target: DISARM THERAPEUTICS

Bidder: ELI LILLY AND COMPANY

5 Service Providers

4 Target | 1 Bidder

7 Dealmakers

2 Target | 5 Bidder

£ 103 M

Value

17 Mar 2020|United States|Biotechnology

Target: SIGILON THERAPEUTICS INC

Bidder: BLACKROCK

7 Service Providers

2 Target | 5 Bidder

8 Dealmakers

3 Target | 5 Bidder

£ 65 M

Value

19 Jan 2021|Netherlands|Biotechnology

Target: MERUS B.V.

Bidder: ELI LILLY AND COMPANY

3 Service Providers

1 Target | 2 Bidder

4 Dealmakers

1 Target | 3 Bidder

£ 14 M

Value

14 Jul 2021|United States|Biotechnology

Target: PROTOMER TECHNOLOGIES

Bidder: ELI LILLY AND COMPANY

5 Service Providers

3 Target | 2 Bidder

16 Dealmakers

6 Target | 10 Bidder

£ 722 M

Value

24 Apr 2023|United States|Pharmaceuticals

Target: BAQSIMI

Bidder: AMPHASTAR PHARMACEUTICALS

14 Service Providers

10 Bidder | 4 Vendor

8 Dealmakers

3 Bidder | 5 Vendor

£ 866 M

Value

14 Jul 2023|United States|Biotechnology

Target: VERSANIS

Bidder: ELI LILLY AND COMPANY

7 Service Providers

5 Target | 2 Bidder

26 Dealmakers

8 Target | 18 Bidder

£ 1.47 B

Value

03 Oct 2023|United States|Biotechnology

Target: POINT BIOPHARMA

Bidder: ELI LILLY AND COMPANY

7 Service Providers

3 Target | 4 Bidder

40 Dealmakers

16 Target | 24 Bidder

£ 1.15 B

Value

11 Jul 2023|United States|Biotechnology

Target: CROSSBOW THERAPEUTICS

Bidder: MIRAE ASSET VENTURE INVESTMENT

8 Service Providers

2 Target | 6 Bidder

9 Dealmakers

3 Target | 6 Bidder

£ 62 M

Value

08 Jul 2024|United States|Biotechnology

Target: MORPHIC HOLDING INC

Bidder: ELI LILLY AND COMPANY

9 Service Providers

6 Target | 3 Bidder

53 Dealmakers

48 Target | 5 Bidder

£ 2.50 B

Value